Exposure to inorganic nanoparticles: Routes of entry, immune response, biodistribution and in vitro/In vivo toxicity evaluation

Toxics

Volumn 5, Issue 4, 2017, Pages

  De Matteis, Valeria ^a  

^a UNIVERSITY OF SALENTO   (Italy)

Author keywords

Biodistribution; Immune response; In vitro in vivo toxicity; Inorganic nanoparticles; Routes of entry

Indexed keywords

EID: 85033714384     PISSN: None     EISSN: 23056304     Source Type: Journal    
DOI: 10.3390/toxics5040029     Document Type: Review

References (172)

1. Nanotechnologies Vocabulary Part 1: Core Terms. ISO/TS 80004-1: 2010. 2010. Available online: https://www.iso.org/standard/51240.html (accessed on 12 October 2017)
2. Technical Specification: Nanotechnologies Terminology and Definitions for Nano-Objects Nanoparticle, Nanofibre and Nanoplate. ISO/TS 80004-2: 2008. 2008. Available online: https://www.iso.org/standard/44278.html (accessed on 12 October 2017)
3. Buzea, C.; Pacheco, I.I.; Robbie, K. Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases 2007, 2, MR17-MR71
4. Ray, P.C.; Yu, H.; Fu, P.P. Toxicity and Environmental Risks of Nanomaterials: Challenges and Future Needs. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 2009, 27, 1-35
5. Kumar Rai, P. Multifaceted health impacts of Particulate Matter (PM) and its management: An overview. Environ. Skept. Critics 2015, 4, 1-26
6. Borm, P.J.A.; Robbins, D.; Haubold, S.; Kuhlbusch, T.; Fissan, H.; Donaldson, K.; Schins, R.; Stone, V.; Kreyling, W.; Lademann, J.; et al. The potential risks of nanomaterials: A review carried out for ECETOC. Part. Fibre Toxicol. 2006, 14, 11
7. Pilling, M.; ApSimon, H.; Carruthers, D.; Carslaw, D.; Roy, C.; Derwent, D.; Dorling, S.; Fisher, B.; Harrison, R.; Heal, M.; et al. AQEG Particulate Matter in the United Kingdom; Defra Publications: London, UK, 2005; pp. 1-144, ISBN 0-85521-143-1
8. Hoyt, V.W.; Mason, E. Nanotechnology: Emerging health issues. J. Chem. Heal. Saf. 2008, 15, 10-15
9. Silva, G.A. Neuroscience nanotechnology: Progress, opportunities and challenges. Nat. Rev. Neurosci. 2006, 7, 65-74
10. De la Fuente, J.M.; Grazu, V. Nanobiotechnology: Inorganic Nanoparticles vs. Organic Nanoparticles; Frontiers of Nanoscience, Elsevier: Oxford, UK, 2012; pp. 1-520, ISBN 978-012-415769-9
11. Gatoo, M.A.; Naseem, S.; Arfat, M.Y.; Dar, A.M.; Qasim, K.; Zubair, S. Physicochemical Properties of Nanomaterials: Implication in Associated Toxic Manifestations. Biomed. Res. Int. 2014, 2014, 498420
12. Mu, Q.; Jiang, G.; Chen, L.; Zhou, H.; Fourches, D.; Tropsha, A.; Yan, B. Chemical Basis of Interactions Beetween Engineered Nanoparticles and Biological Systems. Chem. Rev. 2014, 114, 7740-7781
13. Oberdörster, G.; Maynard, A.; Donaldson, K.; Castranova, V.; Fitzpatrick, J.; Ausman, K.; Carter, J.; Karn, B.; Kreyling, W.; Lai, D.; et al. ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group. Principles for characterizing the potential human health effects from exposure to nanomaterials: Elements of a screening strategy. Part. Fibre Toxicol. 2005, 2, 8
14. Jiang, J.; Oberdörster, G.; Biswas, P. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J. Nanopart. Res. 2009, 11, 77-89
15. Powers, K.W.; Brown, S.C.; Krishna, V.B.; Wasdo, S.C.; Moudgil, B.M.; Roberts, S.M. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol. Sci. 2006, 90, 296-303
16. 2 particles: Differential responses related to surface properties. Toxicology 2007, 230, 90-104
17. Shvedova, A.A.; Kisin, E.R.; Mercer, R.; Murray, A.R.; Johnson, V.J.; Potapovich, A.I.; Tyurina, Y.Y.; Gorelik, O.; Arepalli, S.; Schwegler-Berry, D.; et al. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 2005, 289, L698-L708
18. Buford, M.; Hamilton, R.; Holian, A. A comparison of dispersing media for various engineered carbon nanoparticles. Part. Fibre Toxicol. 2007, 4, 6
19. Sager, T.M.; Porter, D.W.; Robinson, V.A.; Lindsley, W.G.; Schwegler-Berry, D.E.; Castranova, V. Improved method to disperse nanoparticles for in vitro and in vivo investigation of toxicity. Nanotoxicology 2007, 1, 118-129
20. Moore, T.L.; Rodriguez-Lorenzo, L.; Hirsch, V.; Balog, S.; Urban, D.; Corinne, J.; Rothen-Rutishauser, B.; Lattuada, M.; Petri-Fink, A. Nanoparticle colloidal stability in cell culture media and impact on cellular interactions. Chem. Soc. Rev. 2015, 44, 6287-6305
21. Alkilany, A.M.; Murphy, C.J. Toxicity and cellular uptake of gold nanoparticles: What we have learned so far? J. Nanopart. Res. 2010, 12, 2313-2333
22. Ma, D.D.; Yang, W.X. Engineered nanoparticles induce cell apoptosis: Potential for cancer therapy. Oncotarget 2015, 28, 40882-40903
23. Oberdörster, G.; Stone, V.; Donaldson, K. Toxicology of nanoparticles: A historical perspective. Nanotoxicology 2007, 1, 2-25
24. Oberdörster, G. Safety assessment for nanotechnology and nanomedicine: Concepts of nanotoxicology. J. Intern. Med. 2010, 267, 89-105
25. Hund-Rinke, K.; Herrchen, M.; Schlich, K.; Schwirn, K.; Völker, D. Test strategy for assessing the risks of nanomaterials in the environment considering general regulatory procedures. Environ. Sci. Eur. 2015, 27, 1-12
26. Stone, V.; Johnston, H.; Schins, R.P.F. Development of in vitro systems for nanotoxicology: Methodological considerations. Crit. Rev. Toxicol. 2009, 39, 613-626
27. Fröhlich, E.; Salar-Behzadi, S. Toxicological assessment of inhaled nanoparticles: Role of in vivo, ex vivo, in vitro, and in silico studies. Int. J. Mol. Sci. 2014, 15, 4795-4822
28. Aillon, K.L.; Xie, Y.; El-Gendy, N.; Berkland, C.J.; Forrest, M.L. Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv. Drug Deliv. Rev. 2009, 61, 457-466
29. Raies, A.B.; Bajic, V.B. In silico toxicology: Computational methods for the prediction of chemical toxicity. Wiley Interdiscip. Rev. Comput. Mol. Sci. 2016, 6, 147-172
30. Hegde, K.; Brar, S.K.; Verma, M.; Surampalli, R.Y. Current understandings of toxicity, risks and regulations of engineered nanoparticles with respect to environmental microorganisms. Nanotechnol. Environ. Eng. 2016, 1, 5
31. European CommissionWeb Resource. Available online: http://ec.europa.eu/research/industrial_technologies/policy_en.html (accessed on 12 August 2016)
32. Hansen, S.F.; Michelson, E.S.; Kamper, A.; Borling, P.; Stuer-Lauridsen, F.; Baun, A. Categorization framework to aid exposure assessment of nanomaterials in consumer products. Ecotoxicology 2008, 17, 438-447
33. Chen, X.; Mao, S.S. Nanostructured Titanium Dioxide Materials: Properties, Preparation and Applications. Chem. Rev. 2007, 107, 2891-2959
34. Marin, S.; Vlasceanu, G.M.; Tiplea, R.E.; Bucur, I.R.; Lemnaru, M.; Marin, M.M.; Grumezescu, A.M. Applications and toxicity of silver nanoparticles: A recent review. Curr. Top. Med. Chem. 2015, 15, 1596-1604
35. Boisselier, E.; Astruc, D. Gold nanoparticles in nanomedicine: Preparations, imaging, diagnostics, therapies and toxicity. Chem. Soc. Rev. 2009, 38, 1759-1782
36. Zhao, M.X.; Zhu, B.J. The Research and Applications of Quantum Dots as Nano-Carriers for Targeted Drug Delivery and Cancer Therapy. Nanoscale Res. Lett. 2016, 11, 207
37. McCracken, C.; Zane, A.; Knight, D.A.; Dutta, P.K.;Waldman, W.J. Minimal intestinal epithelial cell toxicity in response to short-and long-term food-relevant inorganic nanoparticle exposure. Chem. Res. Toxicol. 2013, 26, 1514-1525
38. Kaiser, J.P.; Roesslein, M.; Diener, L.; Wick, P. Human health risk of ingested nanoparticles that are added as multifunctional agents to paints: An in vitro study. PLoS ONE 2013, 8, e83215
39. Rim, K.T.; Song, S.W.; Kim, H.Y. Oxidative DNA Damage from Nanoparticle Exposure and Its Application to Workers' Health: A Literature Review. Saf. Health Work 2013, 4, 177-186
40. Faust, J.J.; Doudrick, K.; Yang, Y.; Westerhoff, P.; Capco, D.G. Food grade titanium dioxide disrupts intestinal brush border microvilli in vitro independent of sedimentation. Cell Biol. Toxicol. 2014, 30, 169-188
41. Wei, F.; Wang, Y.; Luo, Z.; Li, Y.; Duan, Y. New findings of silica nanoparticles induced ER autophagy in human colon cancer cell. Sci. Rep. 2017, 7, 42591
42. 2 on human epithelial intestinal HT-29 cell line. Ann. Occup. Hyg. 2012, 56, 622-630
43. Böhmert, L.; Girod, M.; Hansen, U.; Maul, R.; Knappe, P.; Niemann, B.; Weidner, S.M.; Thünemann, A.F.; Lampen, A. Analytically Monitored Digestion of Silver Nanoparticles and their Toxicity for Human Intestinal Cells. Nanotoxicology 2014, 8, 631-642
44. Tada-Oikawa, S.; Ichihara, G.; Fukatsu, H.; Shimanuki, Y.; Tanaka, N.;Watanabe, E.; Suzuki, Y.; Murakami, M.; Izuoka, K.; Chang, J.; et al. Titanium Dioxide Particle Type and Concentration Influence the Inflammatory Response in Caco-2 Cells. Int. J. Mol. Sci. 2016, 17, 576
45. Koeneman, B.A.; Zhang, Y.; Westerhoff, P.; Chen, Y.; Crittenden, J.C.; Capco, D.G. Toxicity and cellular responses of intestinal cells exposed to titanium dioxide. Cell. Biol. Toxicol. 2010, 26, 225-238
46. Yao, M.; He, L.; McClements, D.J.; Xiao, H. Uptake of Gold Nanoparticles by Intestinal Epithelial Cells: Impact of Particle Size on Their Absorption, Accumulation, and Toxicity. J. Agric. Food Chem. 2015, 63, 8044-8049
47. Wang, L.; Nagesha, D.K.; Selvarasah, S.; Dokmeci, M.R.; Carrier, R.L. Toxicity of CdSe Nanoparticles in Caco-2 Cell Cultures. J. Nanobiotech. 2008, 6, 11
48. Yoshida, T.; Yoshioka, Y.; Takahashi, H.; Misato, K.; Mori, T.; Hirai, T.; Nagano, K.; Abe, Y.; Mukai, Y.; Kamada, H.; et al. Intestinal absorption and biological effects of orally administered amorphous silica particles. Nanoscale Res. Lett. 2014, 9, 532
49. Loeschner, K.; Hadrup, N.; Qvortrup, K.; Larsen, A.; Gao, X.; Vogel, U.; Mortensen, A.; Lam, H.R.; Larsen, E.H. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part. Fibre Toxicol. 2011, 8, 18
50. Hadrup, N.; Lam, H.R. Oral toxicity of silver ions, silver nanoparticles and colloidal silver-A review. Regul. Toxicol. Pharmacol. 2014, 68, 1-7
51. Van der Zande, M.; Vandebriel, R.J.; Van Doren, E.; Kramer, E.; Herrera Rivera, Z.; Serrano-Rojero, C.S.; Gremmer, E.R.; Mast, J.; Peters, R.J.; Hollman, P.C.; et al. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano 2012, 6, 7427-7442
52. Yeong, G.N.; Jo, U.B.; Ryu, H.Y.; Kim, Y.S.; Song, K.S.; Yu, I.J. lHistochemical study of intestinal mucins after administration of silver nanoparticles in Sprague-Dawley rats. Arch. Toxicol. 2010, 84, 63-69
53. Blank, F.; Gehr, P.; Rutishauser, R.R. In Vitro Human Lung Cell Culture Models to Study the Toxic Potential of Nanoparticles; JohnWily & Sons Ltd.: Chichester, UK, 2009
54. Patra, H.K.; Banerjee, S.; Chaudhuri, U.; Lahiri, P.; Dasgupta, A.K. Cell selective response to gold nanoparticles. Nanomedicine 2007, 3, 111-119
55. Bengalli, R.; Gualtieri, M.; Capasso, L.; Urani, C.; Camatini, M. Impact of zinc oxide nanoparticleson an in vitro model of the human air-blood barrier. Toxicol. Lett. 2017, 279, 22-32
56. Vandebriel, R.J.; De Jong, W.H. A review of mammalian toxicity of ZnO nanoparticles. Nanotechnol. Sci. Appl. 2012, 5, 61-71
57. Lee, Y.S.; Kim, D.W.; Lee, Y.H.; Oh, J.H.; Yoon, S.; Choi, M.S.; Lee, S.K.; Kim, J.W.; Lee, K.; Song, C.W. Silver nanoparticles induce apoptosis and G2/M arrest via PKCζ-dependent signaling in A549 lung cells. Arch. Toxicol. 2011, 85, 1529-1540
58. Nguyen, K.C.; Seligy, V.L.; Massarsky, A.; Moon, T.W.; Rippstein, P.; Tan, J.; Tayabali, A.F. Comparison of toxicity of uncoated and coated silver nanoparticles. J. Phys. 2013, 429, 012025
59. De Matteis, V.; Malvindi, M.A.; Galeone, A.; Brunetti, V.; De Luca, E.; Kote, S.; Kshirsagar, P.; Sabella, S.; Bardi, G.; Pompa, P.P. Negligible particle-specific toxicity mechanism of silver nanoparticles: The role of Ag+ ion release in the cytosol. Nanomed. Nanotechnol. Biol. Med. 2015, 11, 731-739
60. McCarthy, J.; Inkielewicz-Steepniak, I.; Corbalan, J.J.; Radomski, M.W. Mechanisms of toxicity of amorphous silica nanoparticles on human lung submucosal cells in vitro: Protective effects of fisetin. Chem. Res. Toxicol. 2012, 25, 2227-2235
61. Lin, W.; Huang, Y.W.; Zhou, X.D.; Ma, Y. In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol. Appl. Pharmacol. 2006, 217, 252-259
62. 2) nanoparticles after inhalation in rats. Toxicol. Lett. 2017, 265, 77-85
63. Miller, M.R.; Raftis, J.B.; Langrish, J.P.; McLean, S.G.; Samutrtai, P.; Connell, S.P.; Wilson, S.; Vesey, A.T.; Fokkens, P.H.B.; Boere, A.J.F.; et al. Inhaled Nanoparticles Accumulate at Sites of Vascular Disease. ACS Nano 2017, 11, 4542-4552
64. Xue, C.;Wu, J.; Lan, F.; Liu, W.; Yang, X.; Zeng, F.; Xu, H. Nano Titanium Dioxide Induces the Generation of ROS and Potential Damage in HaCaT Cells Under UVA Irradiation. J. Nanosci. Nanotechnol. 2010, 10, 8500-8507
65. Sung, J.H.; Ji, J.H.; Yoon, J.U.; Kim, D.S.; Song, M.Y.; Jeong, J.; Han, B.S.; Han, J.H.; Chung, Y.H.; Kim, J.; et al. Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhal. Toxicol. 2008, 20, 567-574
66. Sung, J.H.; Ji, J.H.; Park, J.D.; Yoon, J.U.; Kim, D.S.; Jeon, K.S.; Song, M.Y.; Jeong, J.; Han, B.S.; Han, J.H.; et al. Subchronic inhalation toxicity of silver nanoparticles. Toxicol. Sci. 2009, 108, 452-461
67. Yang, L.; Kuang, H.; Zhang, W.; Aguilar, Z.P.; Wei, H.; Xu, H. Comparisons of the biodistribution and toxicological examinations after repeated intravenous administration of silver and gold nanoparticles in mice. Sci. Rep. 2017, 7, 3303
68. 2 Nanoparticles Enables Transdermal Penetration. PLoS ONE 2012, 7, e48719
69. De Matteis, V.; Cascione, M.; Brunetti, V.; Toma, C.C.; Rinaldi, R. Toxicity assessment of anatase and rutile titanium dioxide nanoparticles: The role of degradation in different pH conditions and light exposure. Toxicol. In Vitro 2016, 37, 201-210
70. Crosera, M.; Prodi, A.; Mauro, M.; Pelin, M.; Florio, C.; Bellomo, F.; Adami, G.; Apostoli, P.; De Palma, G.; Bovenzi, M.; et al. Titanium Dioxide Nanoparticle Penetration into the Skin and Effects on HaCaT Cells. Int. J. Environ. Res. Public Health 2015, 12, 9282-9297
71. Lee, S.H.; Lee, H.R.; Kim, Y.R.; Kim, M.K. Toxic Response of Zinc Oxide Nanoparticles in Human Epidermal Keratinocyte HaCaT Cells. J. Toxicol. Environ. Health Sci. 2012, 4, 14-18
72. Meyer, K.; Rajanahalli, P.; Ahamed, M.; Rowe, J.J.; Hong, Y. ZnO nanoparticles induce apoptosis in human dermal fibroblasts via p53 and p38 pathways. Toxicol. In Vitro 2011, 25, 1721-1726
73. Tak, Y.K.; Pal, S.; Naoghare, P.K.; Rangasamy, S. Shape-Dependent Skin Penetration of Silver Nanoparticles: Does It Really Matter? Sci. Rep. 2015, 5, 16908
74. Park, Y.H.; Bae, H.C.; Jang, Y.; Jeong, S.H.; Lee, H.N.; Ryu, W.I.; Yoo, M.G.; Kim, Y.R.; Kim, M.K.; Lee, J.K.; et al. Effect of the size and surface charge of silica nanoparticles on cutaneous toxicity. Mol. Cell. Toxicol. 2013, 9, 67-74
75. Nabeshi, H.; Yoshikawa, T.; Matsuyama, K.; Nakazato, Y.; Arimori, A.; Isobe, M.; Tochigi, S.; Kondoh, S.; Hirai, T.; Akase, T.; et al. Amorphous nanosilicas induce consumptive coagulopathy after systemic exposure. Nanotechnology 2012, 23, 045101
76. Pernodet, N.; Fang, X.; Sun, Y.; Bakhtina, A.; Ramakrishnan, A.; Sokolov, J.; Ulman, A.; Rafailovich, M. Adverse effects of citrate/gold nanoparticles on human dermal fibroblasts. Small 2006, 2, 766-773
77. Monteiro-Riviere, N.A. Structure and Function of Skin; In Toxicology of the Skin-Target Organ Series; Monteiro-Riviere, N.A., Ed.; Informa Healthcare: Raleigh, NC, USA, 2010; pp. 1-18, ISBN 9781420079173
78. Sykes, E.A.; Dai, Q.; Tsoi, K.M.; Hwang, D.M.; Chan Warren, C.W. Nanoparticle exposure in animals can be visualized in the skin and analysed via skin biopsy. Nat. Commun. 2014, 5, 3796
79. John, F.; Reinus Douglas, M.D.; Simon, M.D. Gastrointestinal Anatomy and Physiology: The Essentials; JohnWiley & Sons: Oxford, UK, 2014; p. 188, ISBN 978-0-470-67484-0
80. Bergin, I.L.;Witzmann, F.A. Nanoparticle toxicity by the gastrointestinal route: Evidence and knowledge gaps. Int. J. Biomed. Nanosci. Nanotechnol. 2013, 3, 163-210
81. Braakhuis, H.M.; Kloet, S.K.; Kezic, S.; Kuper, F.; Park, M.V.; Bellmann, S.; van der Zande, M.; Le Gac, S.; Krystek, P.; Peters, R.J.; et al. Progress and future of in vitro models to study translocation of nanoparticles. Arch. Toxicol. 2015, 89, 1469-1495
82. Kararli, T. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm. Drug Dispos. 1995, 16, 351-380
83. Manson, J.M.; Rauch, M.; Gilmore, M.S. The commensal microbiology of the gastrointestinal tract. In GI Microbiota and Regulations of the Immune System; Huffnagle, G.B., Noverr, M., Eds.; Advances in Experimental Medicine and Biology, 635; Springer: New York, NY, USA, 2008; p. 15
84. Hansson, G.C. Role of mucus layers in gut infection and inflammation. Curr. Opin. Microbiol. 2012, 15, 57-62
85. Fröhlich, E.E.; Fröhlich, E. Cytotoxicity of Nanoparticles Contained in Food on Intestinal Cells and the Gut Microbiota Esther. Int. J. Mol. Sci. 2016, 17, 509
86. Bellmann, S.; Carlander, D.; Fasano, A.; Momcilovic, D.; Scimeca, J.A.; Waldman, W.J.; Gombau, L.; Tsytsikova, L.; Canady, R.; Pereira, D.I.; et al. Mammalian gastrointestinal tract parameters modulating the integrity, surface properties, and absorption of food-relevant nanomaterials. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2015, 7, 609-622
87. McConnell, E.L.; Basit, A.W.; Murdan, S. Measurements of rat and mouse gastrointestinal, pH, fluid, and lymphoid tissue, and implications for in vivo experiments. J. Pharm. Pharmacol. 2008, 60, 63-70
88. Axson, J.; Stark, D.; Bondy, A.; Capracotta, S.; Maynard, A.; Philbert, M.; Bergin, I.; Ault, A. Rapid kinetics of size and pH-dependent dissolution and aggregation of silver nanoparticles in simulated gastric fluid. J. Phys. Chem. C 2015, 119, 20632-20641
89. Powell, J.J.; Faria, N.; Thomas-McKay, E.; Pele, L.C. Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J. Autoimm. 2010, 34, J226-J233
90. Ahamed, M.; Alsalhi, M.S.; Siddiqui, M.K. Silver nanoparticle applications and human health. Clin. Chim. Acta 2010, 411, 1841-1848
91. Elder, A.; Vidyasagar, S.; DeLouise, L. Physicochemical Factors that AffectMetal andMetal Oxide Nanoparticle Passage across Epithelial Barriers.Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2009, 1, 434-450
92. Powell, J.J.; Thoree, V.; Pele, L.C. Dietary microparticles and their impact on tolerance and immune responsiveness of the gastrointestinal tract. Br. J. Nutr. 2007, 98, S59-S63
93. Lomer, M.C.; Thompson, R.P.; Powell, J.J. Fine and ultrafine particles of the diet: Influence on the mucosal immune response and association with Crohn's disease. Proc. Nutr. Soc. 2002, 61, 123-130
94. Busquets, R. Emerging Nanotechnologies in Food Science; Elsevier: Oxford, UK, 2017; pp. 1-238, ISBN 9780323429993
95. Kaida, T.; Kobayashi, K.; Adachi, M.; Suzuki, F. Optical characteristics of titanium oxide interference film and the film laminated with oxides and their applications for cosmetics. J. Cosmet. Sci. 2004, 55, 219-220
96. Weir, A.;Westerhoff, P.; Fabricius, L.; Hristovski, K.; von Goetz, N. Titanium dioxide nanoparticles in food and personal care products. Environ. Sci. Technol. 2012, 46, 2242-2250
97. Lomer, M.C.; Thompson, R.P.; Commisso, J.; Keen, C.L.; Powell, J.J. Determination of titanium dioxide in foods using inductively coupled plasma optical emission spectrometry. Analyst 2000, 125, 2339-2343
98. Vance, M.E.; Kuiken, T.; Vejerano, E.P.; McGinnis, S.P.; Hochella, M.F.; Rejeski, D.; Hull, M.S. Nanotechnology in the real world: Redeveloping the nanomaterial consumer products inventory. Beilstein J. Nanotechnol. 2015, 6, 1769-1780
99. World Health Organization. Silver in Drinking-Water. Background Document for Preparation of Who Guidelines for Drinking-Water Quality. WHO/SDE/WSH/03.04/14. 2003. Available online: http://www. who.int/entity/water_sanitation_health/dwq/chemicals/silver.pdf (accessed on 12 August 2016)
100. Dekkers, S.; Krystek, P.; Peters, R.J.; Lankveld, D.P.; Bokkers, B.G.; van Hoeven-Arentzen, P.H.; Bouwmeester, H.; Oomen, A.G. Presence and risks of nanosilica in food products. Nanotoxicology 2011, 5, 393-405
101. Winkler, H.C.; Suter, M.; Naegeli, H. Critical review of the safety assessment of nano-structured silica additives in food. J. Nanobiotechnol. 2016, 14, 44
102. Moos, P.J.; Chung, K.;Woessner, D.; Honeggar, M.; Cutler, N.S.; Veranth, J.M. ZnO particulate matter requires cell contact for toxicity in human colon cancer cells. Chem. Res. Toxicol. 2010, 23, 733-739
103. Weibel, E.R. Morphometry of the Human Lung; Springer: New York, NY, USA, 1963
104. Weibel, E.R.; Sapoval, B.; Filoche, M. Design of peripheral airways for efficient gas exchange. Respir. Physiol. Neurobiol. 2005, 148, 3-21
105. Qiao, H.; Liu, W.; Gu, H.; Wang, D.; Wang, Y. The Transport and Deposition of Nanoparticles in Respiratory System by Inhalation. J. Nanomater. 2015, 2015, 394507
106. Bakand, S.; Hayes, A. Toxicological Considerations, Toxicity Assessment, and Risk Management of Inhaled Nanoparticles. Int. J. Mol. Sci. 2016, 17, 929
107. Siegmann, K.; Scherrer, L.; Siegmann, H.C. Physical and chemical properties of airborne nanoscale particles and how to measure the impact on human health. J. Mol. Struct. 1999, 458, 191-201
108. Witschi, H.P. Toxic responses of the respiratory system. In Casarett and Doull's Toxicology: The Basic Science of Poisons, 6th ed.; Klaassen, C.D., Ed.; McGraw-Hill: New York, NY, USA, 2001; pp. 515-534
109. Bakand, S.; Hayes, A.; Dechsakulthorn, F. Nanoparticles: A review of particle toxicology following inhalation exposure. Inhal. Toxicol. 2012, 24, 125-135
110. Tetley, T.D. Health effects of nanomaterials. Biochem. Soc. Trans. 2007, 35, 527-531
111. Muhlfeld, C.; Gehr, P.; Rothen-Rutishauser, B. Translocation and cellular entering mechanisms of nanoparticles in the respiratory tract. Swiss. Med. Wkly. 2008, 138, 387-391
112. Theodorou, I.G.; Ryan, M.P.; Tetley, T.D.; Porter, A.E. Inhalation of Silver Nanomaterials-Seeing the Risks. Int. J. Mol. Sci. 2014, 15, 23936-23974
113. Hillery, A.M.; Lloyd, A.W.; Swarbrick, J. Drug Delivery and Targeting for Pharmacists and Pharmaceutical Scientist; Taylor & Francis: London, UK, 2001
114. Yhee, J.Y.; Im, J.; Nho, R.S. Advanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug Delivery. J. Clin. Med. 2016, 5, 82
115. Wickett, R.R.; Visscher, M.O. Structure and function of the epidermal barrier. Am. J. Infect. Control 2006, 34, s98-s110
116. Niska, K.; Zielinska, E.; Radomski, M.W.; Inkielewicz-Stepniak, I. Metal nanoparticles in dermatology and cosmetology: Interactions with human skin cells. Chem. Biol. Interact. 2017
117. Piccinno, F.; Gottschalk, F.; Seeger, S.; Nowack, B. Industrial production quantities and uses of ten engineered nanomaterials in Europe and the world. J. Nanopart. Res. 2012, 14, 1109
118. Donnelly, R.F.; Singh, T.R.R.; Morrow, D.I.;Woolfson, A.D. Microneedle-Mediated Transdermal and Intradermal Drug Delivery;Wiley-Blackwell: Hoboken, NJ, USA, 2012; pp. 1-216
119. Watkinson, A.C.; Bunge, A.L.; Hadgraft, J.; Lane, M.E. Nanoparticles Do Not Penetrate Human Skin-A Theoretical Perspective. Pharm. Res. 2013, 30, 1943-1946
120. Filon, F.L.; Mauro, M.; Adami, G.; Bovenzi, M.; Crosera, M. Nanoparticles skin absorption: New aspects for a safety profile evaluation. Regul. Toxicol. Pharmacol. 2015, 72, 310-322
121. Rancan, F.; Gao, Q.; Graf, C.; Troppens, S.; Hadam, S.; Hackbarth, S.; Kembuan, C.; Blume-Peytavi, U.; Rühl, E.; Lademann, J.; et al. Skin Penetration and Cellular Uptake of Amorphous Silica Nanoparticles with Variable Size, Surface Functionalization, and Colloidal Stability. ACS Nano 2012, 6, 6829-6842
122. Lin, W.W.; Karin, M. A cytokine-mediated link between innate immunity, inflammation and cancer. J. Clin. Investig. 2007, 117, 1175-1183
123. Scheller, J.; Chalaris, A.; Schmidt-Arras, D.; Rose-John, S. The pro-and antiinflammatory properties of the cytokine Interleukin-6. Biochim. Biophys. Acta 2011, 1813, 878-888
124. David, D.; Chaplin, M.D. Overview of the Immune Response. J. Allergy Clin. Immunol. 2010, 125, S3-S23
125. Dobrovolskaia, M.A.; McNeil, S.E. Immunological properties of engineered nanomaterials. Nat. Nanotechnol. 2007, 2, 469-478
126. Dobrovolskaia, M.A.; Aggarwal, P.; Hall, J.B.; McNeil, S.E. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol. Pharm. 2008, 5, 487-495
127. Aggarwal, P.; Hall, J.B.; McLeland, C.B.; Dobrovolskaia, M.A.; McNeil, S.E. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev. 2009, 61, 428-437
128. Fard, K.J.; Jafari, S.; Eghbal, M.A. Review of Molecular Mechanisms Involved in Toxicity of Nanoparticles. Adv. Pharm. Bull. 2015, 5, 447-454
129. Tan, Y.; Li, S.; Pitt, B.R.; Huang, L. The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo. Hum. Gene Ther. 1999, 10, 2153-2161
130. Fleischer, C.C.; Payne, C.K. Nanoparticle surface charge mediates the cellular receptors used by protein-nanoparticle complexes. J. Phys. Chem. B 2012, 116, 8901-8907
131. Mahon, E.; Salvati, A.; Baldelli Bombelli, F.; Lynch, I.; Dawson, K.A. Designing the nanoparticle-biomolecule interface for targeting and therapeutic delivery. J. Control Release 2012, 161, 164-174
132. 2 nanoparticles synergistically trigger macrophage inflammatory responses. Part. Fibre Toxicol. 2017, 14, 11
133. 2 nanoparticles on human peripheral blood mononuclear cells. J. Appl. Toxicol. 2016, 36, 1364-1373
134. Murphy, A.; Casey, A.; Byrne, G.; Chambers, G.; Howe, O. Silver nanoparticles induce pro-inflammatory gene expression and inflammasome activation in human monocytes. J. Appl. Toxicol. 2016, 36, 1311-1320
135. Castillo, P.M.; Herrera, J.L.; Fernandez-Montesinos, R.; Caro, C.; Zaderenko, A.P.; Mejias, J.A.; Pozo, D. Tiopronin monolayer-protected silver nanoparticles modulate IL-6 secretion mediated by Toll-like receptor ligands. Nanomedicine 2008, 3, 627-663
136. Park, J.; Lim, D.H.; Lim, H.J.; Kwon, T.; Choi, J.S.; Jeong, S.; Choi, I.H.; Cheon, J. Size dependent macrophage responses and toxicological effects of Ag nanoparticles. Chem. Commun. 2011, 47, 4382-4384
137. Khan, H.A.; Abdelhalim, A.A.M.K.; Alhomida, A.S.; Al-Ayed, M.S. Effects of Naked Gold Nanoparticles on Proinflammatory Cytokines mRNA Expression in Rat Liver and Kidney. BioMed. Res. Int. 2013, 2013, 590730
138. Falagan-Lotscha, P.; Grzincica, E.M.; Murphy, C.J. One low-dose exposure of gold nanoparticles induces long-term changes in human cells. Proc. Natl. Acad. Sci. USA 2016, 113, 13318-13323
139. Durocher, I.; Noël, C.; Lavastre, V.; Girard, D. Evaluation of the in vitro and in vivo proinflammatory activities of gold (+) and gold (-) nanoparticles. Inflamm. Res. 2017, 66, 981-992
140. Chen, H.; Dorrigan, A.; Saad, S.; Hare, D.J.; Cortie, M.B.; Valenzuela, S.M. In vivo Study of Spherical Gold Nanoparticles: Inflammatory Effects and Distribution in Mice. PLoS ONE 2013, 8, e58208
141. Senapati, V.A.; Gupta, G.S.; Pandey, A.K.; Shankera, R.; Dhawan, A.; Kumar, A. Zinc oxide nanoparticle induced age dependent immunotoxicity in BALB/c mice. Toxicol. Res. 2017, 6, 342-352
142. Giovanni, M.; Yue, J.; Zhang, L.; Xie, J.; Ong, C.N.; Leong, D.T. Pro-Inflammatory Responses of RAW264.7 Macrophages when Treated with Ultralow Concentrations of Silver, Titanium Dioxide, and Zinc Oxide Nanoparticles. J. Hazard Mater. 2015, 297, 146-152
143. Lu, Y.; Xu, S.; Chen, H.; He, M.; Deng, Y.; Cao, Z.; Pi, H.; Chen, C.; Li, M.; Ma, Q.; et al. CdSe/ZnS quantum dots induce hepatocyte pyroptosis and liver inflammation via NLRP3 inflammasome activation. Biomaterials 2016, 90, 27-39
144. Wang, X.; Tian, J.; Yong, K.T.; Zhu, X.; Lin, M.C.; Jiang, W.; Li, J.; Huang, Q.; Lin, G. Immunotoxicity assessment of CdSe/ZnS quantum dots in macrophages, lymphocytes and BALB/c mice. J. Nanobiotechnol. 2016, 14, 10
145. Lankoff, A.; Sandberg, W.J.; Wegierek-Ciuk, A.; Lisowska, H.; Refsnes, M.; Sartowska, B.; Schwarze, P.E. The effect of agglomeration state of silver and titanium dioxide nanoparticles on cellular response of HepG2, A549 and THP-1 cells. Toxicol. Lett. 2012, 208, 197-213
146. Kovács, D.; Igaz, N.; Keskeny, C.; Bélteky, P.; Tóth, T.; Gáspár, R.; Madarász, D. Silver nanoparticles defeat p53-positive and p53-negative osteosarcoma cells by triggering mitochondrial stress and apoptosis. Sci. Rep. 2016, 6
147. Chueha, P.J.; Lianga, R.Y.; Leea, Y.H.; Zenga, Z.; Chuang, S.M. Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines. J. Hazard Mater. 2014, 264, 303-312
148. Zhang, Y.; Ferguson, S.A.; Watanabe, F.; Jones, Y.; Xu, Y.; Biris, A.S.; Hussain, S.; Ali, S.F. Silver nanoparticles decrease body weight and locomotor activity in adult male rats. Small 2013, 9, 1715
149. Knudsen, K.B.; Northeved, H.; Ek, P.K.; Permin, A.; Andresen, T.L.; Larsen, S.;Wegener, K.M.; Lam, H.R.; Lykkesfeldt, J. Differential toxicological response to positively and negatively charged nanoparticles in the rat brain. Nanotoxicology 2014, 8, 764-774
150. Kolosnjaj-Tabi, J.; Volatron, J.; Gazeau, F. Basic Principles of In vivo Distribution, Toxicity, and Degradation of Prospective Inorganic Nanoparticles for Imaging. In Design and Applications of Nanoparticles in Biomedical Imaging; Bulte, J., Modo, M., Eds.; Springer: Cham, Switherland, 2017
151. Casals, E.; Vàzquez-Campos, S.; Bastùs, N.G.; Puntes, V. Distribution and potential toxicity of engineered inorganic nanoparticles and carbon nanostructures in biological systems. Trends Anal. Chem. 2008, 27, 8
152. Kumar, R.; Roy, I.; Ohulchanskky, T.Y.; Vathy, L.A.; Bergey, E.J.; Sajjad, M.; Prasad, P.N. In vivo Biodistribution and Clearance Studies Using Multimodal Organically Modified Silica Nanoparticles. ACS Nano 2010, 4, 699-708
153. He, X.; Nie, H.; Wang, K.; Tan, W.; Wu, X.; Zhang, P. In vivo Study of Biodistribution and Urinary Excretion of Surface-Modified Silica Nanoparticles. Anal. Chem. 2008, 80, 9597-9603
154. Borak, B.; Biernat, P.; Prescha, A.; Baszczuk, A.; Pluta, J. In vivo study on the biodistribution of silica particles in the bodies of rats. Adv. Clin. Exp. Med. 2012, 21, 13-18
155. Xue, Y.; Zhang, S.; Huang, Y.; Zhang, T.; Liu, X.; Hu, Y.; Zhang, Z.; Tang, M. Acute toxic effects and gender-related biokinetics of silver nanoparticles following an intravenous injection in mice. J. Appl. Toxicol. 2012, 32, 890-899
156. Wang, Z.; Qu, G.; Su, L.;Wang, L.; Yang, Z.; Jiang, J.; Liu, S.; Jiang, G. Evaluation of the biological fate and the transport through biological barriers of nanosilver in mice. Curr. Pharm. Des. 2013, 19, 6691-6697
157. Dziendzikowska, K.; Gromadzka-Ostrowska, J.; Lankoff, A.; Oczkowski, M.; Krawczynska, A.; Chwastowska, J.; Sadowska-Bratek, M.; Chajduk, E.; Wojewódzka, M.; Dušinská, M.; et al. Time-dependent biodistribution and excretion of silver nanoparticles in maleWistar rats. J. Appl. Toxicol. 2012, 32, 920-928
158. Garcia, T.X.; Costa, G.M.; Franca, L.R.; Hofmann, M.C. Sub-acute intravenous administration of silver nanoparticles in male mice alters Leydig cell function and testosterone levels. Reprod. Toxicol. 2014, 45, 59-70
159. Feng, H.; Pyykko, I.; Zou, J. Hyaluronan up-regulation is linked to renal dysfunction and hearing loss induced by silver nanoparticles. Eur. Arch. Otorhinolaryngol. 2015, 272, 2629-2642
160. Su, C.K.; Liu, H.T.; Hsia, S.C.; Sun, Y.C. Quantitatively profiling the dissolution and redistribution of silver nanoparticles in living rats using a knotted reactorbased differentiation scheme. Anal. Chem. 2014, 86, 8267-8274
161. Guo, H.; Zhang, J.; Boudreau, M.; Meng, J.; Yin, J.J.; Liu, J.; Xu, H. Intravenous administration of silver nanoparticles causes organ toxicity through intracellular ROS-related loss of interendothelial junction. Part Fibre Toxicol. 2016, 13, 21
162. Chen, J.; Dong, X.; Zhao, J.; Tang, G. In vivo acute toxicity of titanium dioxide nanoparticles to mice after intraperitioneal injection. J. Appl. Toxicol. 2009, 29, 330-337
163. Jia, X.; Wang, S.; Zhou, L.; Sun, L. The Potential Liver, Brain, and Embryo Toxicity of Titanium Dioxide Nanoparticles on Mice. Nanoscale Res. Lett. 2017, 12, 478
164. Takeuchi, I.; Nobata, S.; Oiri, N.; Tomoda, K.; Makino, K. Biodistribution and excretion of colloidal gold nanoparticles after intravenous injection: Effects of particle size. Biomed. Mater. Eng. 2017, 28, 315-323
165. Wang, J.Y.; Chen, J.; Yang, J.;Wang, H.; Shen, X.; Sun, Y.M.; Guo, M.; Zhang, X.D. Effects of surface charges of gold nanoclusters on long-term in vivo biodistribution, toxicity, and cancer radiation therapy. Int. J. Nanomed. 2016, 11, 3475-3485
166. De Jong, W.H.; Hagens, W.I.; Krystek, P.; Burger, M.C.; Sips, A.J.; Geertsma, R.E. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 2008, 29, 1912-1919
167. Balasubramanian, S.K.; Jittiwat, J.; Manikandan, J.; Ong, C.N.; Yu, L.E.; Ong, W.Y. Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rat. Biomaterials 2010, 31, 2034-2042
168. Li, C.H.; Shen, C.C.; Cheng, Y.W.; Huang, S.H.; Wu, C.C.; Kao, C.C.; Liao, J.W.; Kang, J.J. Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice. Nanotoxicology 2012, 6, 746-756
169. Choi, J.; Kim, H.; Kim, P.; Jo, E.; Kim, H.M.; Lee, M.Y.; Jin, S.M.; Park, K. Toxicity of zinc oxide nanoparticles in rats treated by two different routes: Single intravenous injection and single oral administration. J. Toxicol. Environ. Health A 2015, 78, 226-243
170. g2Se in Mice. ACS Appl. Mater. Interfaces 2016, 8, 17859-17869
171. Zhao, Y.; Zhang, Y.; Qin, G.; Cheng, J.; Zeng, W.; Liu, S.; Kong, H.; Wang, X.; Wang, Q.; Qu, H. In vivo biodistribution and behavior of CdTe/ZnS quantum dots. Int. J. Nanomed. 2017, 12, 1927-1939
172. Ribeiro, A.R.; Leite, P.E.; Falagan-Lotsch, P.; Benetti, F.; Micheletti, C.; Budtz, H.C.; Jacobsen, N.R.; Lisboa-Filho, P.N.; Rocha, L.A.; Hristozov, D.K.D.; et al. Challenges on the toxicological prediction of engineered nanoparticles. Nanoimpact 2017, 8, 59-72